Literature DB >> 34290107

mTORC1 Signaling Regulates Proinflammatory Macrophage Function and Metabolism.

Samuel L Collins1, Min-Hee Oh2, Im-Hong Sun3, Yee Chan-Li1, Liang Zhao3, Jonathan D Powell3, Maureen R Horton4.   

Abstract

Metabolic programming is integrally linked to immune cell function. Nowhere is this clearer than in the differentiation of macrophages. Proinflammatory M1 macrophages primarily use glycolysis as a rapid energy source but also to generate antimicrobial compounds, whereas alternatively activated M2 macrophages primarily rely on oxidative phosphorylation for the longevity required for proper wound healing. mTOR signaling has been demonstrated to be a key regulator of immune cell metabolism and function. mTORC2 signaling is required for the generation of M2 macrophages, whereas the role of mTORC1 signaling, a key regulator of glycolysis, has been controversial. By using genetic deletion of mTORC1 signaling in C57BL/6 mouse macrophages, we observed enhanced M1 macrophage function in vitro and in vivo. Surprisingly, this enhancement occurred despite a significant defect in M1 macrophage glycolytic metabolism. Mechanistically, enhanced M1 function occurred because of inhibition of the class III histone deacetylases the sirtuins, resulting in enhanced histone acetylation. Our findings provide a counterpoint to the paradigm that enhanced immune cell function must occur in the presence of increased cellular metabolism and identifies a potential, pharmacologic target for the regulation of inflammatory responses.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Year:  2021        PMID: 34290107     DOI: 10.4049/jimmunol.2100230

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  The Metabolic Control of Myeloid Cells in the Tumor Microenvironment.

Authors:  Eloise Ramel; Sebastian Lillo; Boutaina Daher; Marina Fioleau; Thomas Daubon; Maya Saleh
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

Review 2.  Multistability in Macrophage Activation Pathways and Metabolic Implications.

Authors:  Carsten Geiß; Elvira Salas; Jose Guevara-Coto; Anne Régnier-Vigouroux; Rodrigo A Mora-Rodríguez
Journal:  Cells       Date:  2022-01-25       Impact factor: 6.600

3.  Identifying novel SMYD3 interactors on the trail of cancer hallmarks.

Authors:  Candida Fasano; Martina Lepore Signorile; Katia De Marco; Giovanna Forte; Paola Sanese; Valentina Grossi; Cristiano Simone
Journal:  Comput Struct Biotechnol J       Date:  2022-04-11       Impact factor: 6.155

4.  Inhibition of mTOR in bovine monocyte derived macrophages and dendritic cells provides a potential mechanism for postpartum immune dysfunction in dairy cows.

Authors:  Anja S Sipka; Tawny L Chandler; Thomas Weichhart; Hans-Joachim Schuberth; Sabine Mann
Journal:  Sci Rep       Date:  2022-09-05       Impact factor: 4.996

5.  Novel Insights into the Prognosis and Immunological Value of the SLC35A (Solute Carrier 35A) Family Genes in Human Breast Cancer.

Authors:  Hoang Dang Khoa Ta; Do Thi Minh Xuan; Wan-Chun Tang; Gangga Anuraga; Yi-Chun Ni; Syu-Ruei Pan; Yung-Fu Wu; Fenny Fitriani; Elvira Mustikawati Putri Hermanto; Muhammad Athoillah; Vivin Andriani; Purity Sabila Ajiningrum; Chih-Yang Wang; Kuen-Haur Lee
Journal:  Biomedicines       Date:  2021-11-30

6.  Triiodothyronine (T3) Induces Limited Transcriptional and DNA Methylation Reprogramming in Human Monocytes.

Authors:  Rebecca Shepherd; Bowon Kim; Richard Saffery; Boris Novakovic
Journal:  Biomedicines       Date:  2022-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.